Waltz Health and Fresenius Kabi are moving to offer three biosimilars through a direct-to-payer model, bypassing traditional wholesaler and pharmacy benefit manager rebate channels entirely. The partnership represents a significant shift in
New York Governor Kathy Hochul has signed a landmark bill granting private and public sector employees the right to access and dispute their personnel records. The legislation, known as S3460, adds a
MoreThe legal profession has long been resistant to change, with many lawyers continuing practices that technological advances have rendered entirely unnecessary. Many habits followed in law firms today were commonplace decades ago
MoreThe FTSE 100 index of leading British shares hit an all-time high over the summer, and remains only a few percentage points below that record level. The broader UK economy, however, tells
MoreSerie A dominated global football in the nineties and noughties, with names like Maldini, Totti and Gattuso recognised from Naples to Salford. That prestige has faded considerably, and data shows Italian football
MoreMatt Turner, President of Patient Affordability at Paysign (PAYS), has introduced ClaimGuardRx, a proprietary large language model built to protect manufacturer affordability program value. The platform is designed to ensure that every
MoreNew York City’s newly enacted pied-a-terre tax is drawing significant attention from legal experts, property owners, and policymakers across the United States. The tax, formally known as the non-primary residence property surcharge,
MoreWeil made legal industry history this week, becoming the first firm ever to describe Cravath as offering a “smaller platform” to departing talent. The remarkable characterisation came after Weil lost its corporate
MoreVail Resorts (MTN) is facing a potential board-level dispute that analysts suggest could have meaningful consequences for how investors view the stock. Board conflicts at major leisure and hospitality companies often signal
MoreSchroder Real Estate Investment Trust has issued more than 450 million new shares following the completion of its acquisition of Picton Property Income. The share issuance marks a significant milestone in the
MoreThe pharmaceutical industry has largely solved the challenge of adopting artificial intelligence, but a harder problem is now taking centre stage: how to properly supervise it. Amy Brown, founder and CEO of
More
